Company profile
BrainChild Bio
BrainChild Bio develops CAR-T cell therapies for pediatric brain tumors, focusing on DIPG.
- Location
- Seattle, Washington, United States, North America
- Website
- brainchildbio.com
Latest known funding
Series A round
- Capital
- $116M
- Announced
- Sep 7, 2026